PharmaZac is one of the most dynamic pharmaceutical firms in Greece and an important player in manufacturing, exports and healthcare.

Research & Development

PharmaZac is investing more than 15% of its annual income on new products, technologies and infastructure.


We understand how a modern Pharmaceutical company should function. PharmaZac provides a full array of services from Sales, Marketing and Business Development to Distribution & Logistics.


PharmaZac offers a wide range of more than 90 products in the therapeutic areas of Cardiology, Oncology, CNS, Urology, Dermatology, Contrast Media, Antibiotics & Orthopaedics.

Latest News
  • Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules of 70,4 mg P A free, under the trade name Petagran. Petagran / Petasitis hybridus is effective in reducing......

  • Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and the pain sings of inflammation associated with acute gouty arthritis....

  • Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders....

  •   Pharmazac a Member of the Hellenic Association of Pharmaceutical Companies,  announces the completion of the successful Conference of the Hellenic Society of Headache,  that took place  on 15 – 17  of  March 2018  at the Museum of Cycladic Art in Athens....


Years of Research & Development


Business Units


European Awards


Global Certifications

Memberships & Awards

  • Pharmazac is a proud member of the Hellenic Pharmaceutical Industry Association with an active intervention in policy making and regulatory changes.
  • Pharmazac is regularly inspected by the Authorities and International Clients for its logistics, distribution and wholesale commercial best practices. In 2016 the company’s GDP has been renewed.
  • As a permanent member of the Generics Association Pharmazac has joined the working committees and is an active participant.
  • The implementation of Good Manufacturing Practice is certified by local and international authorities while a robust QA system suns through the company’s operations.
  • Pharmazac first received an ISO Certificate in 1997 and has been audited without interruption since then.
  • Pharmazac is a regular member of Hellenic Association of Pharmaceutical Companies


We are getting bigger
Are you interested in working in an awarded pharmaceutical company?